Skip to main content

Day: October 28, 2020

GOWEST GOLD: Receives Mining Permit for Full Production, Commissions Ore-Sorter and Agrees to Mill Processing Schedule

TORONTO, Oct. 28, 2020 (GLOBE NEWSWIRE) — Gowest Gold Ltd. (“Gowest” or the “Company”) (TSX VENTURE: GWA) is pleased to provide a further update on its progress towards bringing the Company’s 100% owned Bradshaw Gold Deposit (“Bradshaw”) into production.Greg Romain, Gowest President, said, “We have just achieved two more critical milestones towards seeing the Bradshaw gold deposit as the newest gold mine in the Timmins camp. We appreciate the patience and support of our many stakeholders and look forward to providing further detail as we move towards production.”Mining Production PermitGowest has received official notice from the Ontario’s Ministry of Energy, Northern Development and Mines (“ENDM”) that the Company’s Mine Production Closure Plan (“the Closure Plan”) has received final review and filing in accordance with the Ontario...

Continue reading

CB2 Insights enters Washington with acquisition of Primary Care Medical Clinic with $0.7 million in Revenue and Positive EBITDA

Washington-based Tacoma medical clinic owned by Dr. Jackson has been providing Primary Care Services to over 10,000 patients in University Place and surrounding regions.In 2019, the clinic generated CAD 0.7 million in revenues and CAD 0.1 million in net income.CB2 Insights will continue to expand services offered by Dr. Jackson including deployment of its proprietary telehealth platform to support patients across the state of Washington.This transaction joins recently acquired Texas clinic adding collectively CAD 2.3 million in incremental annualized revenue from acquisitions for the Company.CB2 Insights paid a total cash consideration of CAD 0.37 million for the acquisition.TORONTO, Oct. 28, 2020 (GLOBE NEWSWIRE) — CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), one of the largest multi-specialty healthcare systems...

Continue reading

miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.

Acquisition includes clinical stage anti-IGF–1R monoclonal antibody, VRDN-001, intended for the treatment of thyroid eye disease (TED)Company plans to use private placement financing proceeds of $91 million to advance multiple compounds through phase 2 proof of concept studies in TED and to expand its orphan disease pipelineConference Call and Webcast today at 9:00 a.m. EDTBOULDER, Colo. and WALTHAM, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) —  miRagen Therapeutics, Inc. (“miRagen”) (NASDAQ: MGEN) today announced it has completed the acquisition of Viridian Therapeutics, Inc. (“Viridian”), a privately held biotechnology company focused on advancing new treatments for patients with diseases that are underserved by today’s therapies. Concurrent with the acquisition of Viridian, miRagen entered into a definitive agreement for the...

Continue reading

Dimensional Fund Advisors Ltd. : Form 8.3 – KAZ MINERALS PLC – Ordinary Shares

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)*Dimensional Fund Advisors Ltd. and / or its affiliates do not control voting discretion for 267,651 shares.All interests and all short positions should be disclosed.Details of any open stock-settled derivative...

Continue reading

CorVel’s Vasantha Prammagnanam Wins Business Insurance 2020 Women to Watch Award

IRVINE, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) — Vasantha Prammagnanam, Vice President of Information Systems at CorVel Corporation (NASDAQ: CRVL), has been named a winner of the 2020 Women to Watch award by Business Insurance. The award program, which began in 2006, recognizes women leaders doing outstanding work in risk management and commercial insurance.The award recognizes Prammagnanam’s contributions to the insurance industry, her focus on enhancing technology tools to improve the claims management process, and her work to advocate for women in the industry, specifically in technology.“Vasantha has been a valued part of CorVel’s team for nearly 20 years, and we are thrilled that she is being honored,” said Michael Combs, CorVel’s Chief Executive Officer. “Vasantha is an inspiring leader who motivates everyone around her to...

Continue reading

VSBLTY AND BRANDING GLOBAL ENHANCE DIGITAL SIGNAGE/SECURITY TECHNOLOGY AT GUATEMALA CITY’S INTERNATIONAL AIRPORT

Philadelphia, PA, Oct. 28, 2020 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC: VSBGF) (“VSBLTY”), a leading provider of security and retail marketing technology, today announced that it has partnered with Branding Global, a Latin American comprehensive advertising network operator, to deploy a network of cameras at La Aurora International Airport in Guatemala City, Guatemala. The announcement was made jointly by Jay Hutton, Co-founder and CEO of VSBLTY, and Branding Global CEO Douglas Ovalle.“The deployment at the airport that handles 2.7 million passengers annually provides enhanced security by scanning visitors looking for persons of interest. Simultaneously, as visitors are looking at the signage, it also gathers real-time audience analytics,” Hutton said. Audience measurement includes overall...

Continue reading

Kraig Biocraft Laboratories Delivers Recombinant Spider Silk Silkworm Eggs to Production Facility in Vietnam

ANN ARBOR, Mich., Oct. 28, 2020 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), announces that it has delivered its latest batch of spider silk silkworm eggs to its production facility in Vietnam.This delivery marks the first shipment of the Company specialized recombinant spider silk silkworm eggs to Vietnam since the global outbreak of COVID-19. With restrictions on operations and travel in Vietnam now lifting, the Company is able to resume the scale up of spider silk production.“With our silkworms now delivered, we are moving quickly, resuming production, and working to develop opportunities with apparel brands to bring exciting new products to market,” said CEO and Founder Kim Thompson. “We believe that this delivery puts us back on track with our plans for production and further...

Continue reading

Verona Pharma plc : Update on AIM Delisting

LONDON and RALEIGH, N.C., Oct. 28, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), provides a further update with regards to its intended Delisting and Cancellation of its Ordinary Shares from Trading on AIM, as announced on September 21, 2020.As previously announced, the last day of trading of the Company’s Ordinary Shares on AIM will be October 29, 2020 and the proposed AIM Delisting will be effective from 7.00 am London time on October 30, 2020. Verona Pharma will retain the listing of its ADSs on the Nasdaq Global Market under ticker symbol VRNA. Following the AIM Delisting, shares will only be tradeable on Nasdaq.Further information about the process to convert Ordinary Shares into ADSs was provided in the announcement published by the Company on September 21, 2020 and...

Continue reading

MediPharm Labs Sets Date to Release Third Quarter 2020 Financial Results

TORONTO, Oct. 28, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce it will release third quarter financial results for the three and nine month period ended September 30, 2020 before markets open on Monday, November 16, 2020.MediPharm Labs executive management team will also host a conference call and audio webcast on Monday November 16, 2020, at 8:30 a.m. eastern time to discuss the Company’s financial results and outlook.Audio Conference Call Dial In Details:Toll-free number: +1-833-502-0471 / International number: +1-236-714-2179 / Conference ID: 7656805Participants are asked to dial in approximately 15 minutes...

Continue reading

G1 Therapeutics to Provide Third Quarter 2020 Corporate and Financial Update on November 4, 2020

RESEARCH TRIANGLE PARK, N.C., Oct. 28, 2020 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that it will host a webcast and conference call to provide a corporate and financial update for the third quarter of 2020 on Wednesday, November 4, 2020 at 4:30 p.m. ET.The live call may be accessed by dialing 866-763-6020 (domestic) or 210-874-7713 (international) and entering the conference code: 6634419. The live and archived webcast will be available on the Events & Presentations page of the G1 website.About G1 TherapeuticsG1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer. The company is developing and advancing two novel therapies: trilaciclib is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.